- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
-
- Mohamed F Attia
- CNRS, CAMB, UMR 7199, Université de Strasbourg , Strasbourg,
-
- Nicolas Anton
- CNRS, CAMB, UMR 7199, Université de Strasbourg , Strasbourg,
-
- Justine Wallyn
- CNRS, CAMB, UMR 7199, Université de Strasbourg , Strasbourg,
-
- Ziad Omran
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Umm Al-Qura University , Umm Al-Qura,
-
- Thierry F Vandamme
- CNRS, CAMB, UMR 7199, Université de Strasbourg , Strasbourg,
Search this article
Description
<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Objectives</jats:title> <jats:p>This review highlights both the physicochemical characteristics of the nanocarriers (NCs) and the physiological features of tumour microenvironment (TME) to outline what strategies undertaken to deliver the molecules of interest specifically to certain lesions. This review discusses these properties describing the convenient choice between passive and active targeting mechanisms with details, illustrated with examples of targeting agents up to preclinical research or clinical advances.</jats:p> </jats:sec> <jats:sec> <jats:title>Key findings</jats:title> <jats:p>Targeted delivery approaches for anticancers have shown a steep rise over the past few decades. Though many successful preclinical trials, only few passive targeted nanocarriers are approved for clinical use and none of the active targeted nanoparticles. Herein, we review the principles and for both processes and the correlation with the tumour microenvironment. We also focus on the limitation and advantages of each systems regarding laboratory and industrial scale.</jats:p> </jats:sec> <jats:sec> <jats:title>Summary</jats:title> <jats:p>The current literature discusses how the NCs and the enhanced permeation and retention effect impact the passive targeting. Whereas the active targeting relies on the ligand-receptor binding, which improves selective accumulation to targeted sites and thus discriminates between the diseased and healthy tissues. The latter could be achieved by targeting the endothelial cells, tumour cells, the acidic environment of cancers and nucleus.</jats:p> </jats:sec>
Journal
-
- Journal of Pharmacy and Pharmacology
-
Journal of Pharmacy and Pharmacology 71 (8), 1185-1198, 2019-08-01
Oxford University Press (OUP)
- Tweet
Details 詳細情報について
-
- CRID
- 1360576120376816000
-
- ISSN
- 20427158
- 00223573
-
- Data Source
-
- Crossref